Macrophages are naturally designed to be the immune system's frontline sentinels. In a healthy tissue response, they adopt a pro-inflammatory, anti-tumor posture (often termed the M1 phenotype) to identify and destroy abnormal cells. However, the tumor microenvironment (TME) actively subverts this defensive posture. By exploiting the inherent plasticity of macrophages, tumors reprogram these cells into an anti-inflammatory, pro-tumor state (the M2 phenotype). Instead of attacking the malignancy, these hijacked macrophages shield the tumor from the rest of the immune system, promote blood vessel growth, and facilitate metastasis.
Understanding why and how this cellular identity theft occurs requires mapping the communication channels between tumor cells and macrophages, the internal rewiring that locks macrophages into this supportive state, and the therapeutic strategies emerging to reverse the process.
Tumor-Derived Messengers: Cytokines and Extracellular Vesicles
Tumor cells do not exist in isolation; they continuously manipulate their surroundings by broadcasting molecular instructions. This communication occurs primarily through two vectors: secreted soluble factors (like cytokines and growth factors) and membrane-bound cargo ships known as extracellular vesicles (EVs) or exosomes.
Soluble factors act as direct biochemical switches. For instance, Lei Yue et al. demonstrated in Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization that the protein Orosomucoid 1 (ORM1) accelerates tumor growth while simultaneously polarizing macrophages toward the M2 phenotype via the PI3K/AKT pathway. Similarly, Shipeng Dai et al. mapped how the miR-455/GREM1 axis promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing M2 macrophage polarization, showing that tumor-driven growth factors neutralize host defenses by forcing this M1-to-M2 shift.
Other secreted families, such as the Growth Differentiation Factors analyzed by Xiaoqian Feng et al. in Single-cell and spatial analyses of the GDF family in tumors, with a focus on the prognostic and biological role of GDF15 in hepatocellular carcinoma, show that factors like GDF15 concurrently suppress anti-tumor M1 activity while driving immunosuppressive M2 polarization. In highly aggressive brain tumors, Wenying Wang et al. found that Interleukin-32 (IL-32) acts as a master microenvironmental switch in IL-32-mediated caspase-43 induction: Shaping macrophage differentiation & immunomodulation in glioblastoma multiforme, shaping macrophage differentiation to protect the tumor.
[Tumor Cell]
│
├──► Secreted Factors (ORM1, GDF15, IL-32) ──► [Macrophage Receptor] ──► M2 Polarization
│
└──► Extracellular Vesicles (EVs/Exosomes) ──► [Internalization] ──► Immunosuppression
To achieve wider, more systemic effects, tumors package complex regulatory cargo into EVs. As reviewed by Lijuan Wang et al. in Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives, these vesicles deliver microRNAs and proteins directly into the macrophage cytoplasm, bypassing standard surface receptor pathways to force a pro-tumor phenotype. This vesicle-mediated communication can even dictate how a tumor responds to clinical interventions. Jincheng Fang et al. highlighted in Role of exosomes in modulating non-small cell lung cancer radiosensitivity that tumor-derived exosomes reprogram local macrophages into an immunosuppressive state that actively shields lung cancer cells from radiation-induced damage.
Intracellular Rewiring: Metabolism and Transcriptional Switches
When these external signals reach a macrophage, they trigger a profound internal reorganization. This transition is governed by a tight coupling between metabolic pathways and transcriptional machinery.
As Guohong Liu et al. explained in Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment, nutrient availability and metabolic flux within the TME are not merely byproducts of tumor growth; they are instructive signals. A macrophage's functional state is directly tied to how it processes energy. Shifting from an M1 to an M2 phenotype requires a complete metabolic pivot that alters gene expression profiles.
At the transcriptional level, specific molecular switches act as gatekeepers for this polarization. For example, Ruihong Zhang et al. discovered in TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer that the transcription factor Sohlh2 is a potent driver of pro-tumor M2 polarization. Under normal conditions, the E3 ubiquitin ligase TRIM21 acts as a critical brake on this process by tagging Sohlh2 for degradation. When the tumor microenvironment disrupts this regulatory balance, Sohlh2 accumulates, locking the macrophage into its pro-tumor state.
Furthermore, the tumor's broader genetic landscape dictates how these immune populations are recruited and altered. Cha Lin et al. demonstrated in A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma that specific genetic risk profiles within a tumor—particularly those disrupting calcium signaling—strongly correlate with the systematic recruitment and M2 polarization of surrounding macrophages, shaping a "cold," treatment-resistant microenvironment.
Constructing the Immunosuppressive Shield and Metastatic Niche
Why do tumors invest so much energy into reshaping macrophages? The primary return on this investment is the construction of a protective shield that neutralizes other immune cells, particularly cytotoxic T cells, and prepares distant organs for colonization.
Once polarized, M2 macrophages express specific surface markers that actively suppress immune surveillance. Maofa Zheng et al. showed in 1401 Siglec15 induces monocyte apoptosis and an Siglec15 antibody ES012 reverses myeloid cells driven immunosuppression that inhibitory markers like Siglec15 are selectively expressed on pro-tumorigenic M2 macrophages. This selective expression creates a defensive barrier around the tumor, inducing apoptosis in incoming monocytes and dampening broader immune homeostasis.
[M2 Macrophage] ──► Expresses Siglec15 ──► Induces Monocyte Apoptosis ──► T-Cell Suppression
│
▼
[Immune Evasion]
This protective environment is critical when tumor cells leave the primary site to colonize distant organs. In Emerging mechanisms progress of colorectal cancer liver metastasis, Wenhu Zhao et al. detailed how tumor-derived factors travel ahead of migrating cancer cells to polarize resident immune cells in target organs like the liver. This pre-polarization creates a hospitable, immunosuppressive niche that protects arriving metastatic cells from local host defenses.
This polarization cascade can be accelerated by unexpected systemic and microenvironmental triggers:
- Platelet Aggregation: Yuyi Chen et al. found in Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment that tumor-induced platelet aggregation triggers rapid macrophage recruitment and subsequent M2 polarization within the metastatic niche.
- Collateral Damage from Cell Death: Even therapeutic pathways can backfire. As explained by Shuang Wu et al. in Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes, while inducing ferroptotic cell death is a viable strategy to kill tumor cells, the resulting cellular debris releases signaling molecules that can inadvertently polarize neighboring macrophages toward a pro-tumor state.
- Systemic Stressors: Environmental factors also influence this axis. Haocheng Xian et al. demonstrated in Antimetastatic Effects of Ganoderma lucidum Polysaccharide Peptide on B16-F10-luc-G5 Melanoma Mice With Sleep Fragmentation that systemic disruptions, such as chronic sleep fragmentation, accelerate systemic inflammation and drive pro-tumor immune cell polarization, fueling cancer progression.
Therapeutic Reversal: Turning the Tide
Because macrophage polarization relies on cellular plasticity rather than permanent genetic mutation, the process is theoretically reversible. If tumors can reprogram macrophages to protect themselves, therapeutic interventions can attempt to "re-polarize" them back into tumor-attacking M1 cells.
A compelling example of this strategy involves hijacking the tumor's own preferred communication channel: extracellular vesicles. Xiaojun Wang et al. investigated this approach in Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects. Instead of using tumor-derived vesicles that suppress the immune system, the authors isolated and functionalized extracellular vesicles derived from healthy M1 macrophages.
When deployed against glioblastoma, these engineered vesicles accumulated effectively within the tumor site. By delivering pro-inflammatory cues directly into the immunosuppressive microenvironment, they successfully counteracted the tumor's reprogramming efforts. This type of therapeutic reversal demonstrates that understanding the precise molecular and vesicle-mediated mechanisms of macrophage polarization provides a viable blueprint for forcing the immune microenvironment to turn back against the tumor.
Key Foundational Work
Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects (2016) — contributed 2 concept elements to this direction.
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments (2019) — contributed 1 concept elements to this direction.